# To Demonstrate the Effect of Food on the Bioavailability of Glipizide

> **NCT00947024** · PHASE1 · COMPLETED · sponsor: **Sandoz** · enrollment: 18 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** 10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered Immediately After a Standard Breakfast.
- **DRUG:** 10 mg Glucotrol Tablet (Roerig), Administered Immediately After a Standard Breakfast.
- **DRUG:** 10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered After an Overnight Fast.

## Key facts

- **NCT ID:** NCT00947024
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-11
- **Primary completion:** 1993-11
- **Final completion:** 1993-11
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947024, "To Demonstrate the Effect of Food on the Bioavailability of Glipizide". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00947024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*